Correlation between Prognosis and HER2 status in Advanced/Recurrent Gastric Cancer: Multicenter Retrospective Analysis

Correlation between Prognosis and HER2 status in Advanced/Recurrent Gastric Cancer: Multicenter Retrospective Analysis - HER2 Gastric Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006451

Enrollment

300

Registered

2011-10-01

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced/Recurrent Gastric Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: For 1), 2), 4) and 5), patients who meet the following criteria at the baseline of the first line chemotherapy 1) Histologically confirmed gastric or gastroesophageal junction adenocarcinoma 2) Unresectable advanced or recurrent cancer 3) Patients who received S-1 plus cisplatin as the first line chemotherapy during Jan, 2006 and Mar, 2010 4) Age >= 20 5) PS: 0-2 (ECOG performance status score) 6) Archived tumor material

Exclusion criteria

Exclusion criteria: 1) Patients who refuse the use of clinical information and material for this study 2) Patients with active malignancy at the baseline of the first line chemotherapy

Design outcomes

Primary

Measure	Time frame
correlation between prognosis and HER2 status in advanced/recurrent gastric cancer	—

Countries

Japan

Contacts

Public ContactNozomu Fuse

National Cancer Center Hospital East Gastrointestinal Oncology

nofuse@east.ncc.go.jp04-7133-1111

Outcome results